{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:20:33Z","timestamp":1778631633829,"version":"3.51.4"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T00:00:00Z","timestamp":1415577600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0110787","type":"journal-article","created":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T19:11:56Z","timestamp":1415646716000},"page":"e110787","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Increased Bone Marrow (BM) Plasma Level of Soluble CD30 and Correlations with BM Plasma Level of Interferon (IFN)-\u03b3, CD4\/CD8 T-Cell Ratio and Disease Severity in Aplastic Anemia"],"prefix":"10.1371","volume":"9","author":[{"given":"Qingqing","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jizhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meili","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingqi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizhou","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,11,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0140-6736(05)66515-4","article-title":"Aplastic anaemia","volume":"365","author":"RA Brodsky","year":"2005","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2141.2008.07450.x","article-title":"Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia","volume":"144","author":"P Scheinberg","year":"2009","journal-title":"Br J Haematol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2141.1984.tb06063.x","article-title":"Analysis of lymphocyte subsets in patients with aplastic anaemia","volume":"58","author":"NC Zoumbos","year":"1984","journal-title":"Br J Haematol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood-2002-01-0035","article-title":"Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia","volume":"100","author":"E Sloand","year":"2002","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/blood-2002-01-0236","article-title":"Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDR3 spectratyping and flow cytometry","volume":"100","author":"AM Risitano","year":"2002","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/MOH.0b013e3282fa7470","article-title":"Aplastic anemia","volume":"15","author":"NS Young","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1172\/JCI200112687","article-title":"Limited heterogeneity of T cell receptor BV usage in aplastic anemia","volume":"108","author":"W Zeng","year":"2001","journal-title":"J Clin Invest"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(04)16724-X","article-title":"In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing","volume":"364","author":"AM Risitano","year":"2004","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1182\/blood-2002-11-3409","article-title":"Autoantibodies frequently detected in patients with aplastic anemia","volume":"102","author":"N Hirano","year":"2003","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2141.2004.05317.x","article-title":"Presence of anti-kinectin and anti-PMS1 antibodies in Japanese aplastic anaemia patients","volume":"128","author":"N Hirano","year":"2005","journal-title":"Br J Haematol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4049\/jimmunol.182.1.703","article-title":"Anti-moesin antibodies in the serum of patients with aplastic anemia stimulate peripheral blood mononuclear cells to secrete TNF-alpha and IFN-gamma","volume":"182","author":"H Takamatsu","year":"2009","journal-title":"J Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/bjh.12116","article-title":"Identification of autoantibodies expressed in acquired aplastic anaemia","volume":"160","author":"M Goto","year":"2013","journal-title":"Br J Haematol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.4049\/jimmunol.178.7.4159","article-title":"Minor antigen h60-mediated aplastic anemia is ameliorated by immunosuppression and the infusion of regulatory T cells","volume":"178","author":"J Chen","year":"2007","journal-title":"J Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.4049\/jimmunol.151.5.2380","article-title":"CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells","volume":"151","author":"TM Ellis","year":"1993","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.4049\/jimmunol.153.7.2861","article-title":"CD30 defines a subset of activated human T cells that produce IFN-gamma and IL-5 and exhibit enhanced B cell helper activity","volume":"153","author":"M Alzona","year":"1994","journal-title":"J Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/00007890-199805150-00016","article-title":"CD30 expression identifies a functional alloreactive human T-lymphocyte subset","volume":"65","author":"OM Martinez","year":"1998","journal-title":"Transplantation"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.4049\/jimmunol.169.4.1784","article-title":"CD30 expression identifies the predominant proliferating T lymphocyte population in human alloimmune responses","volume":"169","author":"KW Chan","year":"2002","journal-title":"J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"6703","DOI":"10.4049\/jimmunol.165.12.6703","article-title":"CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme","volume":"165","author":"HP Hansen","year":"2000","journal-title":"J Immunol"},{"key":"ref19","first-page":"1269","article-title":"Soluble CD30 serum level\u2013an adequate marker for allograft rejection of solid organs?","volume":"22","author":"G Schlaf","year":"2007","journal-title":"Histol Histopathol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2249.1995.tb03851.x","article-title":"High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints","volume":"102","author":"R Gerli","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2133.1997.18031887.x","article-title":"Elevated serum levels of soluble CD30 are associated with atopic dermatitis, but not with respiratory atopic disorders and allergic contact dermatitis","volume":"137","author":"W Dummer","year":"1997","journal-title":"Br J Dermatol"},{"key":"ref22","first-page":"339","article-title":"Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity","volume":"13","author":"F Caligaris-Cappio","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.trim.2010.07.001","article-title":"A prospective study of serum soluble CD30 in allogeneic hematopoietic stem cell transplantation","volume":"23","author":"K Hubel","year":"2010","journal-title":"Transpl Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1182\/blood-2012-03-415422","article-title":"Expression of CD30 in patients with acute graft-versus-host disease","volume":"120","author":"YB Chen","year":"2012","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1158\/1078-0432.CCR-11-1425","article-title":"A phase I weekly dosing study of brentuximab vedotin in patients with relapsed\/refractory CD30-positive hematologic malignancies","volume":"18","author":"MA Fanale","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa1002965","article-title":"Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas","volume":"363","author":"A Younes","year":"2010","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3109\/10428194.2013.775434","article-title":"Brentuximab vedotin (SGN-35) in patients with transplant-naive relapsed\/refractory Hodgkin lymphoma","volume":"54","author":"S Sasse","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1200\/JCO.2011.38.0402","article-title":"Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study","volume":"30","author":"B Pro","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1182\/blood.V53.3.504.504","article-title":"A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia","volume":"53","author":"BM Camitta","year":"1979","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2009.07842.x","article-title":"Guidelines for the diagnosis and management of aplastic anaemia","volume":"147","author":"JC Marsh","year":"2009","journal-title":"Br J Haematol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0092-8674(00)81031-4","article-title":"Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice","volume":"84","author":"R Amakawa","year":"1996","journal-title":"Cell"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4049\/jimmunol.163.1.194","article-title":"CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway","volume":"163","author":"R Chiarle","year":"1999","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1182\/blood-2006-07-038455","article-title":"Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease","volume":"109","author":"R Zeiser","year":"2007","journal-title":"Blood"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/cimm.1997.1228","article-title":"CD30-regulated apoptosis in murine CD8+ T cells after cessation of TCR signals","volume":"182","author":"WG Telford","year":"1997","journal-title":"Cell Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/TP.0b013e318296fd69","article-title":"Release of soluble CD30 after allogeneic stimulation is mediated by memory T cells and regulated by IFN-gamma and IL-2","volume":"96","author":"SY Velasquez","year":"2013","journal-title":"Transplantation"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.4049\/jimmunol.173.3.2174","article-title":"Increased expression and activation of CD30 induce apoptosis in human blood eosinophils","volume":"173","author":"AI Berro","year":"2004","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1182\/blood.V96.13.4307","article-title":"Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells","volume":"96","author":"SS Mir","year":"2000","journal-title":"Blood"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10875-007-9135-6","article-title":"Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications","volume":"28","author":"N Rezaei","year":"2008","journal-title":"J Clin Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/cncr.20613","article-title":"Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management","volume":"101","author":"D Couriel","year":"2004","journal-title":"Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1084\/jem.20020319","article-title":"Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus","volume":"196","author":"M Saraiva","year":"2002","journal-title":"J Exp Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0110787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:59:24Z","timestamp":1689641964000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0110787"}},"subtitle":[],"editor":[{"given":"Vassiliki A.","family":"Boussiotis","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,10]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0110787","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,10]]}}}